Successful Antiviral Treatment with Direct-Acting Antivirals for Hepatitis C Virus Infection during Peritransplant Period in a Kidney Transplant Recipient

Introduction. Hepatitis C virus (HCV) infection continues to represent a poor prognostic factor in kidney transplant (KTx) patients. New direct-acting antiviral agents (DAA) have dramatically changed the therapy management for HCV, showing promising results in terms of sustained virologic response....

Descripción completa

Detalles Bibliográficos
Autores principales: Varotti, Giovanni, Dodi, Ferdinando, Paoletti, Ernesto, Bruno, Andrea, Fontana, Iris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684507/
https://www.ncbi.nlm.nih.gov/pubmed/34931152
http://dx.doi.org/10.1155/2021/1948560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684507/
https://www.ncbi.nlm.nih.gov/pubmed/34931152
http://dx.doi.org/10.1155/2021/1948560

Ejemplares similares